AA
RPRX icon

ALPS Advisors’s Royalty Pharma RPRX Stock Holding History

ALPS Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.8M Sell
496,682
-24,101
-5% -$1.06M 0.11% 118
2025
Q4 		$20.1M Sell
520,783
-32,341
-6% -$1.23M 0.12% 125
2025
Q3 		$19.5M Buy
+553,124
New +$20M 0.11% 134
2024
Q3 		– Sell
-11,488
Closed -$303K – 1114
2024
Q2 		$303K Sell
11,488
-62
-0.5% -$1.72K ﹤0.01% 841
2024
Q1 		$351K Buy
+11,550
New +$340K ﹤0.01% 832
2021
Q3 		– Sell
-7,232
Closed -$296K – 1005
2021
Q2 		$296K Hold
7,232
– – ﹤0.01% 839
2021
Q1 		$315K Buy
+7,232
New +$343K ﹤0.01% 796

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $95.1B AUM 30.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return